Literature DB >> 1842408

Cell mediated immunity in Chagas' disease. Trypanosoma cruzi antigens induce suppression of the in vitro proliferative response of mononuclear cells.

W Mosca1, L Briceño, M I Hernández.   

Abstract

The partial suppression of the cell-mediated immune response by Trypanosoma cruzi antigens in patients with Chagas' disease is demonstrated in a costimulation assay with T. cruzi antigens and Mycobacterium tuberculosis purified protein derivative (PPD) or Tetanus toxoid (TT). Mononuclear cells from 13 patients with chagasic infection without evidence of heart disease, 10 patients with chagasic cardiomyopathy and 7 healthy blood bank donors were stimulated with antigen A (autoclaved epimastigotes), PPD, TT, PPD + A, PPD + TT and TT + A. The average percentage of suppression induced by costimulation of mononuclear cells with PPD and antigen A was 47.1% in patients with chagasic infection without heart disease (INF), 38.8% in patients with chagasic cardiomyopathy (CDM) and 23.3% in healthy controls. Similar values were observed when living trypomastigotes were used. A costimulatory study with PPD and TT, PPD and A and TT and A was carried out in 8 patients with chagasic infection, in order to evaluate the possibility that this difference could be due to a nonspecific inhibitory effect. The mean suppression induced by TT + PPD was -8.9, with TT + A was 52.7 and with PPD + A was 50.1. The data reported show that T. cruzi antigens induce a specific suppression of the proliferative response of mononuclear cells, that might be relevant to the persistence of the parasite in the host.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1842408     DOI: 10.1590/s0074-02761991000200002

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  5 in total

Review 1.  Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease.

Authors:  Fabiana S Machado; Walderez O Dutra; Lisia Esper; Kenneth J Gollob; Mauro M Teixeira; Stephen M Factor; Louis M Weiss; Fnu Nagajyothi; Herbert B Tanowitz; Nisha J Garg
Journal:  Semin Immunopathol       Date:  2012-10-18       Impact factor: 9.623

2.  Changes in Proteome Profile of Peripheral Blood Mononuclear Cells in Chronic Chagas Disease.

Authors:  Nisha Jain Garg; Kizhake V Soman; Maria P Zago; Sue-Jie Koo; Heidi Spratt; Susan Stafford; Zinzi N Blell; Shivali Gupta; Julio Nuñez Burgos; Natalia Barrientos; Allan R Brasier; John E Wiktorowicz
Journal:  PLoS Negl Trop Dis       Date:  2016-02-26

3.  Role of T. cruzi exposure in the pattern of T cell cytokines among chronically infected HIV and Chagas disease patients.

Authors:  Tania Regina Tozetto-Mendoza; Dewton de Moraes Vasconcelos; Karim Yaqub Ibrahim; Ana Marli Christovam Sartori; Rita C Bezerra; Vera Lúcia Teixeira de Freitas; Maria Aparecida Shikanai-Yasuda
Journal:  Clinics (Sao Paulo)       Date:  2017-11       Impact factor: 2.365

4.  T lymphocytes from chagasic patients are activated but lack proliferative capacity and down-regulate CD28 and CD3ζ.

Authors:  Nicolás A Giraldo; Natalia I Bolaños; Adriana Cuellar; Nubia Roa; Zulma Cucunubá; Fernando Rosas; Víctor Velasco; Concepción J Puerta; John M González
Journal:  PLoS Negl Trop Dis       Date:  2013-01-31

5.  Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses.

Authors:  Ana Thereza Chaves; Juliana de Assis Silva Gomes Estanislau; Jacqueline Araújo Fiuza; Andréa Teixeira Carvalho; Karine Silvestre Ferreira; Rafaelle Christine Gomes Fares; Pedro Henrique Gazzinelli Guimarães; Elaine Maria de Souza Fagundes; Maria José Morato; Ricardo Toshio Fujiwara; Manoel Otávio da Costa Rocha; Rodrigo Correa-Oliveira
Journal:  BMC Infect Dis       Date:  2016-04-30       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.